Building flexible and robust analysis frameworks for molecular subtyping of cancers
Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in‐depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequen...
Uložené v:
| Vydané v: | Molecular oncology Ročník 18; číslo 3; s. 606 - 619 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
John Wiley & Sons, Inc
01.03.2024
Wiley |
| Predmet: | |
| ISSN: | 1574-7891, 1878-0261, 1878-0261 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in‐depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequencing data) and technical and uncharacterized biological variance between training and test data can pose challenges in classifying individual samples. In this article, we provide a roadmap for implementing bioinformatics frameworks for molecular profiling of human cancers in a clinical diagnostic setting. We describe a framework for integrating several methods for quality control, normalization, batch correction, classification and reporting, and develop a use case of the framework in breast cancer.
We provide a generally applicable roadmap for implementing data and bioinformatics tools for robust inference of cancer subtypes in a clinical setting, both from raw and processed RNA sequencing data and on a per‐sample basis. We apply the resulting framework to the PAM50 and CIT breast cancer classifiers. |
|---|---|
| AbstractList | Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in‐depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequencing data) and technical and uncharacterized biological variance between training and test data can pose challenges in classifying individual samples. In this article, we provide a roadmap for implementing bioinformatics frameworks for molecular profiling of human cancers in a clinical diagnostic setting. We describe a framework for integrating several methods for quality control, normalization, batch correction, classification and reporting, and develop a use case of the framework in breast cancer. Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in‐depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequencing data) and technical and uncharacterized biological variance between training and test data can pose challenges in classifying individual samples. In this article, we provide a roadmap for implementing bioinformatics frameworks for molecular profiling of human cancers in a clinical diagnostic setting. We describe a framework for integrating several methods for quality control, normalization, batch correction, classification and reporting, and develop a use case of the framework in breast cancer. We provide a generally applicable roadmap for implementing data and bioinformatics tools for robust inference of cancer subtypes in a clinical setting, both from raw and processed RNA sequencing data and on a per‐sample basis. We apply the resulting framework to the PAM50 and CIT breast cancer classifiers. Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in-depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequencing data) and technical and uncharacterized biological variance between training and test data can pose challenges in classifying individual samples. In this article, we provide a roadmap for implementing bioinformatics frameworks for molecular profiling of human cancers in a clinical diagnostic setting. We describe a framework for integrating several methods for quality control, normalization, batch correction, classification and reporting, and develop a use case of the framework in breast cancer.Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in-depth knowledge of bioinformatics tools involved in the processing and analysis of the generated data. Additionally, data incompatibility (e.g., microarray versus RNA sequencing data) and technical and uncharacterized biological variance between training and test data can pose challenges in classifying individual samples. In this article, we provide a roadmap for implementing bioinformatics frameworks for molecular profiling of human cancers in a clinical diagnostic setting. We describe a framework for integrating several methods for quality control, normalization, batch correction, classification and reporting, and develop a use case of the framework in breast cancer. |
| Audience | Academic |
| Author | Pedersen, Christina Bligaard Rene, Lasse Rossing, Maria Bagger, Frederik Otzen Campos, Benito Olsen, Lars Rønn Krishnan, Neeraja M. Panda, Binay Vitting‐Seerup, Kristoffer Wegener, Helene Scheel |
| Author_xml | – sequence: 1 givenname: Christina Bligaard surname: Pedersen fullname: Pedersen, Christina Bligaard organization: Rigshospitalet – Copenhagen University Hospital – sequence: 2 givenname: Benito surname: Campos fullname: Campos, Benito organization: Technical University of Denmark – sequence: 3 givenname: Lasse surname: Rene fullname: Rene, Lasse organization: Technical University of Denmark – sequence: 4 givenname: Helene Scheel surname: Wegener fullname: Wegener, Helene Scheel organization: Technical University of Denmark – sequence: 5 givenname: Neeraja M. surname: Krishnan fullname: Krishnan, Neeraja M. organization: Jawaharlal Nehru University – sequence: 6 givenname: Binay surname: Panda fullname: Panda, Binay organization: Jawaharlal Nehru University – sequence: 7 givenname: Kristoffer surname: Vitting‐Seerup fullname: Vitting‐Seerup, Kristoffer organization: Technical University of Denmark – sequence: 8 givenname: Maria surname: Rossing fullname: Rossing, Maria organization: Rigshospitalet – Copenhagen University Hospital – sequence: 9 givenname: Frederik Otzen surname: Bagger fullname: Bagger, Frederik Otzen organization: Rigshospitalet – Copenhagen University Hospital – sequence: 10 givenname: Lars Rønn orcidid: 0000-0002-6725-7850 surname: Olsen fullname: Olsen, Lars Rønn email: lronn@dtu.dk organization: Technical University of Denmark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38158740$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhS1URB-wZocisWEz0-s4fi1LBbTSoC7o3nIce-TBiQc7UZl_j9OUqUBIyAtfXX3nHj_OOToZ4mAReothjQHqSyy4WEHN8BoTKuAFOjt2TkpNebPiQuJTdJ7zDoAyyeQrdEoEpoI3cIa-fZx86PywrVywP30bbKWHrkqxnfJYSh0O2efKJd3bh5i-lzKmqo_BminoVOWpHQ_7WR9dZfRgbMqv0UunQ7ZvnvYLdP_50_31zWpz9-X2-mqzMpQ2sGrb2pjWkaYxEqiRorWkAyEoFjU2hNtyWgAtTSepxcZIZoQDLlkjiOOEXKDbZWwX9U7tk-91OqiovXpsxLRVOo3eBKsk1k4Ap0YDaTjDotgyYgnRndGYdGXWh2XWPsUfk82j6n02NgQ92DhlVUuQIJjguKDv_0J3cUrloWaKyAYDA_JMbXXx94OLY9JmHqquuBS4boDyQq3_QZXV2d6b8tXOl_4fgndP5lPb2-54698fWoDLBTAp5pysOyIY1BwZNQdEzQFRj5EpCrYoHorX4X-4-nq3qRfhL5uuvxc |
| Cites_doi | 10.1038/ng.2653 10.1093/biostatistics/kxj037 10.3390/cancers12123506 10.1038/nature11252 10.24963/ijcai.2018/490 10.1038/s41587‐020‐0546‐8 10.1186/bcr2635 10.1038/s41389‐019‐0157‐8 10.1038/s41467‐020‐15574‐5 10.1016/j.ccell.2017.06.003 10.1016/j.breast.2015.07.008 10.1038/ng.2764 10.1038/s41588‐021‐00911‐1 10.1158/1078‐0432.CCR‐08‐0196 10.1093/jnci/dju357 10.1200/PO.17.00135 10.1371/journal.pone.0157368 10.1016/j.celrep.2018.03.063 10.1186/s12859‐018‐2435‐4 10.1093/bioinformatics/btv157 10.1080/0284186X.2017.1398416 10.1016/j.celrep.2014.08.073 10.1093/bioinformatics/btg405 10.1002/1878‐0261.12389 10.3389/fgene.2019.01150 10.1016/j.cell.2013.09.034 10.1093/bioinformatics/btn647 10.1186/s12859‐015‐0847‐y 10.1200/JCO.2008.18.1370 10.1038/nature11412 10.1093/annonc/mdw013 10.1093/bioinformatics/btr709 10.3390/biomedicines8050114 10.1158/1078‐0432.CCR‐09‐0449 10.1038/35021093 10.1158/1078‐0432.CCR‐10‐0199 10.1038/ncomms3612 10.1186/1471‐2164‐15‐1008 10.1038/onc.2011.301 10.1093/annonc/mdt384 10.1186/1471‐2407‐9‐409 10.1093/nar/gkab554 10.1186/s12920‐015‐0129‐6 10.1002/path.4280 10.1038/nature08460 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. COPYRIGHT 2024 John Wiley & Sons, Inc. 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2023 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. – notice: 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. – notice: COPYRIGHT 2024 John Wiley & Sons, Inc. – notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 DOA |
| DOI | 10.1002/1878-0261.13580 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1878-0261 |
| EndPage | 619 |
| ExternalDocumentID | oai_doaj_org_article_91af8075ca0347618bf363e33adca13d A798124057 38158740 10_1002_1878_0261_13580 MOL213580 |
| Genre | researchArticle Journal Article |
| GeographicLocations | Canada United States |
| GeographicLocations_xml | – name: Canada – name: United States |
| GrantInformation_xml | – fundername: Otto Mønsted Foundation – fundername: Danmarks Frie Forskningsfond funderid: 8048‐00078A – fundername: Danmarks Frie Forskningsfond grantid: 8048-00078A |
| GroupedDBID | --- --K .~1 0R~ 0SF 123 1B1 1OC 1~. 24P 4.4 457 4G. 53G 5VS 6I. 7-5 71M 8FE 8FH 8P~ AACTN AAEDW AAFTH AAFWJ AAHHS AAIKJ AALRI AAQFI AAXUO ABBQC ABFRF ABGSF ABMAC ABVKL ABWVN ACCFJ ACCMX ACGFO ACGFS ACRPL ACXQS ADBBV ADEZE ADMUD ADNMO ADPDF ADUVX ADVLN AEEZP AEFWE AEKER AENEX AEQDE AEXQZ AFKRA AFPKN AGHFR AGYEJ AITUG AIWBW AJBDE AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMRAJ AOIJS AVUZU BAWUL BBNVY BCNDV BENPR BHPHI BLXMC CCPQU CS3 DIK DU5 E3Z EBS EJD EMOBN EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU GBLVA GROUPED_DOAJ HCIFZ HVGLF HYE HZ~ IAO IHE IHR ITC IXB J1W LK8 M41 M7P MO0 N9A NCXOZ O-L OAUVE OK1 OVD OVEED OZT P-8 P-9 P2P PC. PIMPY PROAC Q38 RIG ROL RPM RPZ SDF SDG SEL SES SSZ TEORI TR2 UNMZH WIN 7X7 88E 8FI 8FJ 9DU AAMMB AAYWO AAYXX ABUWG ACVFH ADCNI AEFGJ AEUPX AFFHD AFPUW AGXDD AIDQK AIDYY AIGII AKBMS AKYEP CITATION EFLBG FYUFA HMCUK M1P PHGZM PHGZT PJZUB PPXIY PQGLB PSQYO UKHRP ~HD CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQQKQ PQUKI 7X8 |
| ID | FETCH-LOGICAL-c5540-bb2ccbf344c905c98be3d08851821c37e56900a9cd95e1cc96c8f0796483f733 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001137322100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1574-7891 1878-0261 |
| IngestDate | Fri Oct 03 12:46:32 EDT 2025 Sun Nov 09 14:32:11 EST 2025 Tue Oct 07 06:48:21 EDT 2025 Tue Nov 11 11:04:31 EST 2025 Tue Nov 04 18:22:55 EST 2025 Mon Jul 21 06:05:38 EDT 2025 Sat Nov 29 05:53:48 EST 2025 Wed Jan 22 16:13:31 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | clinical bioinformatics sample classification bioinformatics workflows molecular subtyping |
| Language | English |
| License | Attribution 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5540-bb2ccbf344c905c98be3d08851821c37e56900a9cd95e1cc96c8f0796483f733 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-6725-7850 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1878-0261.13580 |
| PMID | 38158740 |
| PQID | 2939410603 |
| PQPubID | 4370298 |
| PageCount | 619 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_91af8075ca0347618bf363e33adca13d proquest_miscellaneous_2909086871 proquest_journals_2939410603 gale_infotracmisc_A798124057 gale_infotracacademiconefile_A798124057 pubmed_primary_38158740 crossref_primary_10_1002_1878_0261_13580 wiley_primary_10_1002_1878_0261_13580_MOL213580 |
| PublicationCentury | 2000 |
| PublicationDate | March 2024 2024-03-00 2024-Mar 20240301 2024-03-01 |
| PublicationDateYYYYMMDD | 2024-03-01 |
| PublicationDate_xml | – month: 03 year: 2024 text: March 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Molecular oncology |
| PublicationTitleAlternate | Mol Oncol |
| PublicationYear | 2024 |
| Publisher | John Wiley & Sons, Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
| References | 2010; 12 2019; 8 2009; 25 2021; 49 2004; 20 2010; 16 2013; 4 2012; 487 2010 2013; 45 2019; 10 2015; 31 2008; 14 2020; 38 2014; 25 2020; 12 2020; 11 2015; 107 2018; 23 2014; 232 2016; 17 2015; 8 2009; 27 2012; 31 2016; 11 2015; 24 2020; 8 2018; 19 2018; 2 2021; 53 2017; 32 2012; 490 2000; 406 2007; 8 2009; 462 2013; 155 2014; 15 2009; 9 2018 2012; 28 2014; 9 2018; 12 2016; 27 2009; 15 2018; 57 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_20_1 e_1_2_11_45_1 e_1_2_11_46_1 e_1_2_11_47_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_43_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_38_1 e_1_2_11_39_1 e_1_2_11_19_1 |
| References_xml | – volume: 8 start-page: 118 year: 2007 end-page: 127 article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods publication-title: Biostatistics – volume: 15 year: 2014 article-title: Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA‐sequencing technology publication-title: BMC Genomics – volume: 2 year: 2018 article-title: Clinical value of RNA sequencing‐based classifiers for prediction of the five conventional breast cancer biomarkers: a report from the population‐based multicenter Sweden Cancerome Analysis Network‐Breast Initiative publication-title: JCO Precis Oncol – volume: 462 start-page: 108 year: 2009 end-page: 112 article-title: Systematic RNA interference reveals that oncogenic KRAS‐driven cancers require TBK1 publication-title: Nature – volume: 16 start-page: 4864 year: 2010 end-page: 4875 article-title: Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types publication-title: Clin Cancer Res – volume: 28 start-page: 573 year: 2012 end-page: 580 article-title: Robust rank aggregation for gene list integration and meta‐analysis publication-title: Bioinformatics – volume: 49 year: 2021 article-title: Rank‐in: enabling integrative analysis across microarray and RNA‐seq for cancer publication-title: Nucleic Acids Res – volume: 12 start-page: R68 year: 2010 article-title: Phenotypic and molecular characterization of the claudin‐low intrinsic subtype of breast cancer publication-title: Breast Cancer Res – volume: 20 start-page: 307 year: 2004 end-page: 315 article-title: affy – analysis of Affymetrix GeneChip data at the probe level publication-title: Bioinformatics – volume: 31 start-page: 2318 year: 2015 end-page: 2323 article-title: Test set bias affects reproducibility of gene signatures publication-title: Bioinformatics – volume: 406 start-page: 747 year: 2000 end-page: 752 article-title: Molecular portraits of human breast tumours publication-title: Nature – volume: 25 start-page: 32 year: 2014 end-page: 40 article-title: PARP inhibitors for BRCA1/2 mutation‐associated and BRCA‐like malignancies publication-title: Ann Oncol – volume: 23 start-page: 194 year: 2018 end-page: 212.e6 article-title: Genomic, pathway network, and immunologic features distinguishing squamous carcinomas publication-title: Cell Rep – volume: 11 start-page: 1787 year: 2020 article-title: Re‐definition of claudin‐low as a breast cancer phenotype publication-title: Nat Commun – volume: 12 start-page: 2136 year: 2018 end-page: 2146 article-title: Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing publication-title: Mol Oncol – year: 2010 – volume: 53 start-page: 1334 year: 2021 end-page: 1347 article-title: A single‐cell and spatially resolved atlas of human breast cancers publication-title: Nat Genet – volume: 14 start-page: 5198 year: 2008 end-page: 5208 article-title: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome publication-title: Clin Cancer Res – volume: 38 start-page: 675 year: 2020 end-page: 678 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat Biotechnol – volume: 31 start-page: 1196 year: 2012 end-page: 1206 article-title: A refined molecular taxonomy of breast cancer publication-title: Oncogene – volume: 19 start-page: 404 year: 2018 article-title: Single sample scoring of molecular phenotypes publication-title: BMC Bioinformatics – volume: 27 start-page: 599 year: 2016 end-page: 608 article-title: IDH mutations in cancer and progress toward development of targeted therapeutics publication-title: Ann Oncol – volume: 490 start-page: 61 year: 2012 end-page: 70 article-title: Comprehensive molecular portraits of human breast tumours publication-title: Nature – volume: 10 year: 2019 article-title: DNA methylation cancer biomarkers: translation to the clinic publication-title: Front Genet – volume: 8 start-page: 44 year: 2019 article-title: DeepCC: a novel deep learning‐based framework for cancer molecular subtype classification publication-title: Oncogenesis – volume: 9 start-page: 129 year: 2014 end-page: 142 article-title: The prognostic ease and difficulty of invasive breast carcinoma publication-title: Cell Rep – volume: 8 year: 2020 article-title: RNA sequencing in comparison to immunohistochemistry for measuring cancer biomarkers in breast cancer and lung cancer specimens publication-title: Biomedicine – volume: 487 start-page: 330 year: 2012 end-page: 337 article-title: Comprehensive molecular characterization of human colon and rectal cancer publication-title: Nature – volume: 25 start-page: 415 year: 2009 end-page: 416 article-title: arrayQualityMetrics – a bioconductor package for quality assessment of microarray data publication-title: Bioinformatics – volume: 45 start-page: 580 year: 2013 end-page: 585 article-title: The genotype‐tissue expression (GTEx) project publication-title: Nat Genet – volume: 15 start-page: 7003 year: 2009 end-page: 7011 article-title: Microarray‐based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer publication-title: Clin Cancer Res – volume: 32 start-page: 42 year: 2017 end-page: 56.e6 article-title: Tumor evolution of glioma‐intrinsic gene expression subtypes associates with immunological changes in the microenvironment publication-title: Cancer Cell – volume: 57 start-page: 58 year: 2018 end-page: 66 article-title: Molecular subtyping of breast cancer improves identification of both high and low risk patients publication-title: Acta Oncol – start-page: 3527 year: 2018 end-page: 3534 – volume: 9 year: 2009 article-title: Impact of biospecimens handling on biomarker research in breast cancer publication-title: BMC Cancer – volume: 27 start-page: 1160 year: 2009 end-page: 1167 article-title: Supervised risk predictor of breast cancer based on intrinsic subtypes publication-title: J Clin Oncol – volume: 11 year: 2016 article-title: Refinement of triple‐negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection publication-title: PLoS One – volume: 4 start-page: 2612 year: 2013 article-title: Inferring tumour purity and stromal and immune cell admixture from expression data publication-title: Nat Commun – volume: 17 start-page: 5 issue: Suppl 1 year: 2016 article-title: A semi‐parametric statistical model for integrating gene expression profiles across different platforms publication-title: BMC Bioinformatics – volume: 12 year: 2020 article-title: An improved, assay platform agnostic, absolute single sample breast cancer subtype classifier publication-title: Cancers (Basel) – volume: 155 start-page: 462 year: 2013 end-page: 477 article-title: TCGA research network the somatic genomic landscape of glioblastoma publication-title: Cell – volume: 24 start-page: S26 issue: Suppl 2 year: 2015 end-page: S35 article-title: Clinical implications of the intrinsic molecular subtypes of breast cancer publication-title: Breast – volume: 232 start-page: 142 year: 2014 end-page: 150 article-title: Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes publication-title: J Pathol – volume: 107 year: 2015 article-title: Absolute assignment of breast cancer intrinsic molecular subtype publication-title: J Natl Cancer Inst – volume: 45 start-page: 1113 year: 2013 end-page: 1120 article-title: The Cancer Genome Atlas Pan‐Cancer analysis project publication-title: Nat Genet – volume: 8 start-page: 54 year: 2015 article-title: Development and verification of the PAM50‐based prosigna breast cancer gene signature assay publication-title: BMC Med Genomics – ident: e_1_2_11_29_1 doi: 10.1038/ng.2653 – ident: e_1_2_11_25_1 doi: 10.1093/biostatistics/kxj037 – ident: e_1_2_11_44_1 doi: 10.3390/cancers12123506 – ident: e_1_2_11_4_1 doi: 10.1038/nature11252 – ident: e_1_2_11_45_1 doi: 10.24963/ijcai.2018/490 – ident: e_1_2_11_18_1 doi: 10.1038/s41587‐020‐0546‐8 – ident: e_1_2_11_15_1 doi: 10.1186/bcr2635 – ident: e_1_2_11_43_1 doi: 10.1038/s41389‐019‐0157‐8 – ident: e_1_2_11_16_1 doi: 10.1038/s41467‐020‐15574‐5 – ident: e_1_2_11_46_1 doi: 10.1016/j.ccell.2017.06.003 – ident: e_1_2_11_6_1 doi: 10.1016/j.breast.2015.07.008 – ident: e_1_2_11_30_1 doi: 10.1038/ng.2764 – ident: e_1_2_11_47_1 doi: 10.1038/s41588‐021‐00911‐1 – ident: e_1_2_11_7_1 doi: 10.1158/1078‐0432.CCR‐08‐0196 – ident: e_1_2_11_17_1 doi: 10.1093/jnci/dju357 – ident: e_1_2_11_35_1 doi: 10.1200/PO.17.00135 – ident: e_1_2_11_28_1 doi: 10.1371/journal.pone.0157368 – ident: e_1_2_11_5_1 doi: 10.1016/j.celrep.2018.03.063 – ident: e_1_2_11_26_1 doi: 10.1186/s12859‐018‐2435‐4 – ident: e_1_2_11_32_1 doi: 10.1093/bioinformatics/btv157 – ident: e_1_2_11_12_1 doi: 10.1080/0284186X.2017.1398416 – ident: e_1_2_11_13_1 doi: 10.1016/j.celrep.2014.08.073 – ident: e_1_2_11_19_1 doi: 10.1093/bioinformatics/btg405 – ident: e_1_2_11_21_1 doi: 10.1002/1878‐0261.12389 – ident: e_1_2_11_39_1 doi: 10.3389/fgene.2019.01150 – ident: e_1_2_11_23_1 – ident: e_1_2_11_2_1 doi: 10.1016/j.cell.2013.09.034 – ident: e_1_2_11_22_1 doi: 10.1093/bioinformatics/btn647 – ident: e_1_2_11_41_1 doi: 10.1186/s12859‐015‐0847‐y – ident: e_1_2_11_10_1 doi: 10.1200/JCO.2008.18.1370 – ident: e_1_2_11_3_1 doi: 10.1038/nature11412 – ident: e_1_2_11_37_1 doi: 10.1093/annonc/mdw013 – ident: e_1_2_11_42_1 doi: 10.1093/bioinformatics/btr709 – ident: e_1_2_11_36_1 doi: 10.3390/biomedicines8050114 – ident: e_1_2_11_34_1 doi: 10.1158/1078‐0432.CCR‐09‐0449 – ident: e_1_2_11_9_1 doi: 10.1038/35021093 – ident: e_1_2_11_8_1 doi: 10.1158/1078‐0432.CCR‐10‐0199 – ident: e_1_2_11_24_1 doi: 10.1038/ncomms3612 – ident: e_1_2_11_20_1 doi: 10.1186/1471‐2164‐15‐1008 – ident: e_1_2_11_11_1 doi: 10.1038/onc.2011.301 – ident: e_1_2_11_38_1 doi: 10.1093/annonc/mdt384 – ident: e_1_2_11_31_1 doi: 10.1186/1471‐2407‐9‐409 – ident: e_1_2_11_40_1 doi: 10.1093/nar/gkab554 – ident: e_1_2_11_14_1 doi: 10.1186/s12920‐015‐0129‐6 – ident: e_1_2_11_33_1 doi: 10.1002/path.4280 – ident: e_1_2_11_27_1 doi: 10.1038/nature08460 |
| SSID | ssj0056969 |
| Score | 2.365521 |
| Snippet | Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in‐depth knowledge of... Molecular subtyping is essential to infer tumor aggressiveness and predict prognosis. In practice, tumor profiling requires in-depth knowledge of... |
| SourceID | doaj proquest gale pubmed crossref wiley |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | 606 |
| SubjectTerms | Analysis Bioinformatics bioinformatics workflows Biotechnology industry Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - genetics Cancer Classification clinical bioinformatics Computational Biology - methods Estrogens Female Gene expression Gene Expression Profiling - methods Gene Expression Regulation, Neoplastic Genomes Humans Kinases Laboratories molecular subtyping Principal components analysis Quality control RNA RNA sequencing sample classification Tumors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pi9QwFH7IIuJF_G11lQiCXsqkTTNNjrvi4mF3FdzD3kKSJiBoK21H8L_3vaQdZvGwFy9DmGSGzvfyXr7HvHwP4J3omi7gVCmDEGUjfV26ENGvaidctFE7lyx93l5equtr_fWg1RfVhGV54AzcRlc2kmCut1w0mHMrF8VW4BfbzttKdBR9eavXZCrHYLnVqZldJanaUOlqFfXh9aZSpCmLiQO1fCA1yIPzKMn2_xucD06nQwabjqCzh_Bg4Y7sJD_zI7gT-sdw72L5d_wJfDtdelyzSDKX7kdgtu_YOLjdNOMwy4-wuNZj4XAY2c-1QS6bdm7-Q_en2BCZp-0wTk_h6uzT1cfP5dI0ofSSihycq71HjJrGay69Vi6IDkOJxESi8qINiA3nVvtOy1B5r7deRU4XUpWIrRDP4Kgf-vACGMbCluhSy71rkLfYVlnkJ_iiSESRF_BhRc78ytIYJosg14ZANgSySSAXcErI7peRpnV6Ay1tFkub2yxdwHuyiyHPm0fr7XKBAJ-WNKzMSauJrSABLeD4xkr0GH9zerWsWTx2Mkh7dIP5MRcFvN1P0yepCq0Pw47WcI0pIOaYBTzPO2L_k5D5SGpvWMAmbZHbIDEXX87rNHr5P8B5BfdrpFu5Ou4YjuZxF17DXf97_j6Nb5Jz_AX-5wsj priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9UwFD_oFNmL387qlAiCvpSbNu1t8zQ2cfiwTcE93LeQpIkIWzvbXsH_3nPS9O4OQR98KaFJocn5yO-0J78D8FY0ReOwKy2dEGlR2jw1zqNd5UYYr700Jkj6pDo7q1cr-SV-cBtiWuXsE4OjbjpL38gXuC3JAuMXLg6ufqRUNYr-rsYSGrfhDpXNJj2vVpuAq1zKUNIuKynnsJbZTO3D8wWOrlOKP6jwA3FCbu1Kgbz_Txe9tUdt49iwER0_-N8pPIT7EYKyw0lnHsEt1z6Ge6fxJ_sT-HoUS2UzT2yZ5sIx3Tas78x6GLE5sZgwP6d1YbPr2eVcZ5cNazP-omNYrPPMklb1w1M4P_54_uFTGmsvpLakXAljcmuNF0VhJS-trI0TDXqkEuORzIrK4eJyrqVtZOkya-XS1p7TudZa-EqIZ7DTdq17DgxdakWoq-LWFAh_dFVrhDl4qYmLkSfwfl56dTUxbKiJSzlXJCVFUlJBSgkckWg2w4gaO9zo-m8qWpqSmfbEsGw1F0W1zGqcxVKgJurG6kw0CbwjwSoy4LHXVsdzCPi2RIWlDitJoAdxbAL7N0ai4dmb3bOYVTT8QV3LOIE3m256kpLZWtetaQyXGEliqJrA3qRSmykhgCqpSmICi6Bj_1oSdfr5JA-tF39_nZewmyMem9Ln9mFn7NfuFdy1P8fvQ_862M1vfQoZEQ priority: 102 providerName: ProQuest |
| Title | Building flexible and robust analysis frameworks for molecular subtyping of cancers |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1878-0261.13580 https://www.ncbi.nlm.nih.gov/pubmed/38158740 https://www.proquest.com/docview/2939410603 https://www.proquest.com/docview/2909086871 https://doaj.org/article/91af8075ca0347618bf363e33adca13d |
| Volume | 18 |
| WOSCitedRecordID | wos001137322100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: DOA dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: M7P dateStart: 20070601 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: BENPR dateStart: 20070601 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: 7X7 dateStart: 20070601 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: PIMPY dateStart: 20070601 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: WIN dateStart: 20070101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1878-0261 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056969 issn: 1574-7891 databaseCode: 24P dateStart: 20070101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yK-KL3x_Vc6kg6EvZtGk3yeOt3OHB7Vr0wPUpJGkigrbSdgX_e2fSdr3VBxF8CekmLZvJTPKbdvIbQl6wKq8cNCWFYyzJC5slxnmwq8ww47WXxoSZvuCbjdhuZTlGE-JZmIEfYv_CDS0jrNdo4Np0i1-koalAblhwADB1gwCvfZamjKNiZ3k5LcbFUoasdmmBYYdCphO7D80Wvz3gYGMK_P1_rtJXtqmrUDbsRWe3_8Mo7pBbIxCNTwbNuUuuufoeubEeP7XfJ-9XY8Ls2CNnpvniYl1XcduYXddDdeAyif0U3AXVpo2_Ttl2425n-h94GCtufGxRt9ruAbk8O718_SYZMzAktsCICWMya41neW4lLawUxrEK1qUCvJLUMu5AvpRqaStZuNRaubTCUzzdKpjnjD0kR3VTu8ckhoWVI_bi1JocQJDmQgPYgUIgIyONyKtJ-urbwLOhBkblTKGMFMpIBRlFZIWzs--GBNnhh6b9pEZ7UzLVHnmWraYs58tUwCiWDPRRV1anrIrIS5xbhWbct9rq8TQC_FskxFInXCL0ATQbkeODnmB-9rB50g41mn-nAEPJHJxtyiLyfN-Md2JIW-2aHfahEvxJcFgj8mjQqv2QAEYVmCsxIougPH8TiVq_vchC7ck_3_GU3MwAqA1xdcfkqG937hm5br_3n7t2HqwJSr7loRRzMludbsp38_D2Yo6xstA-K8_X5Ue4-nC--QlvbyCb |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VWwRceD8CBYwEgku0Tpxs4gNCLVB11d1lJfZQTpbtOAgJkpJkQf1R_Edm8li2QoJTD1wiK3akOP7m5Yy_AXgmsihz2OXHTgg_im3oG5ejXIVGmFzn0ph2pWfJYpGenMjlDvwczsJQWuWgE1tFnZWW9sjHaJZkhPELF69Pv_lUNYr-rg4lNDpYHLuzHxiy1a-mb3F9n4fh4bvVmyO_ryrg25iyAIwJrTW5iCIreWxlapzIUNZi9LQDKxIXY8DItbSZjF1grZzYNOd0YjMVeUL7n6jxdyPEOh_B7nI6X34cVD8-2dbQC2JKckxlMHAJ8XAcpERli_EKVZogEsotM9hWC_jTJmwZxW3HubV8h9f_s292A671Ljbb72TiJuy44hZcnvdJBLfhw0FfCpzlxAZqvjimi4xVpVnXDTY7lhaWD2lr2Cwr9nWoI8zqtWnO6JgZK3NmSWqq-g6sLmJGd2FUlIW7DwxNRkJeZcKtidC900mq0Y3DS0pck9yDl8NKq9OOQUR1XNGhIlAoAoVqQeHBASFhM4yov9sbZfVJ9ZpEyUDnxCBtNRdRMglSnMVEoKTpzOpAZB68IBwpUlBNpa3uz1ng2xLVl9pPJDl16Kd7sHduJCoWe757QJXqFVutfkPKg6ebbnqSkvUKV65pDJcYKWMo7sG9DsGbKaGDGFMVSA_GLaT_9UnU_P0sbFsP_v46T-DK0Wo-U7Pp4vghXA3R9-xSBfdg1FRr9wgu2e_N57p63AstA3XBkP8FlSJ0_g |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VW1Rx4U0JFDASCC7RJnGyiQ8IdWlXVN0uK-ihN8t2bIQESUmyoP40_h0zeSxbIcGpBy6RFTtSHH_zcsbfADzneZxb7PITy7kfJybytXUoV5Hm2ikntG5Xep4uFtnZmVhuwc_hLAylVQ46sVXUeWloj3yMZknEGL8EfOz6tIjlwezN-TefKkjRn9ahnEYHkWN78QPDt_r10QGu9Ysomh2evn3n9xUGfJNQRoDWkTHa8Tg2IkiMyLTlOcpdgl53aHhqEwweAyVMLhIbGiMmJnMBnd7MuEtpLxS1_3bKMeYZwfb0cLH8MJgBfLKtpxcmlPCYiXDgFQqicZgRrS3GLlR1gggpN0xiWzngT_uwYSA3nejWCs5u_sff7xbc6F1vtt_Jym3YssUd2DnpkwvuwsdpXyKcOWIJ1V8sU0XOqlKv6gabHXsLc0M6GzbLin0d6guzeqWbCzp-xkrHDElTVd-D06uY0X0YFWVhHwBDU5KSt5kGRsfo9qk0U-je4SUjDsrAg1fDqsvzjllEdhzSkSSASAKIbAHiwZRQsR5GlODtjbL6JHsNI0WoHDFLGxXwOJ2EGc5iwlECVW5UyHMPXhKmJCmuplJG9ecv8G2JAkzup4KcPfTfPdi7NBIVjrncPSBM9gqvlr_h5cGzdTc9SUl8hS1XNCYQGEFjiO7Bbofm9ZTQcUyoOqQH4xbe__ok8uT9PGpbD__-Ok9hB3Eu50eL40dwPUKXtMsg3INRU63sY7hmvjef6-pJL78M5BUj_hfCqX2Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Building+flexible+and+robust+analysis+frameworks+for+molecular+subtyping+of+cancers&rft.jtitle=Molecular+oncology&rft.au=Pedersen%2C+Christina+Bligaard&rft.au=Campos%2C+Benito&rft.au=Rene%2C+Lasse&rft.au=Wegener%2C+Helene+Scheel&rft.date=2024-03-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1574-7891&rft.volume=18&rft.issue=3&rft.spage=606&rft_id=info:doi/10.1002%2F1878-0261.13580&rft.externalDocID=A798124057 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1574-7891&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1574-7891&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1574-7891&client=summon |